Form 8-K - Current report:
SEC Accession No. 0001639691-21-000103
Filing Date
2021-11-03
Accepted
2021-11-03 06:04:33
Documents
15
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K livn-20211103.htm   iXBRL 8-K 34739
2 LIVANOVA PRESS RELEASE DATED NOVEMBER 3, 2021 a3q2021earningspressrelease.htm EX-99.1 691726
6 LIVN LOGO downloada03.jpg GRAPHIC 25739
7 livn-20211103_g1.jpg GRAPHIC 6904
  Complete submission text file 0001639691-21-000103.txt   965322

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT livn-20211103.xsd EX-101.SCH 2044
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT livn-20211103_lab.xml EX-101.LAB 25082
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT livn-20211103_pre.xml EX-101.PRE 13245
8 EXTRACTED XBRL INSTANCE DOCUMENT livn-20211103_htm.xml XML 11086
Mailing Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG
Business Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG 4402033250662
LivaNova PLC (Filer) CIK: 0001639691 (see all company filings)

EIN.: 981268150 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37599 | Film No.: 211373577
SIC: 3845 Electromedical & Electrotherapeutic Apparatus